MedPath
HSA Approval

SETISIN INJECTION 2.5 mg/ml

SIN10993P

SETISIN INJECTION 2.5 mg/ml

SETISIN INJECTION 2.5 mg/ml

June 26, 1999

DUOPHARMA (SINGAPORE) PTE LTD

DUOPHARMA (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantDUOPHARMA (SINGAPORE) PTE LTD
Licence HolderDUOPHARMA (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS, SUBCUTANEOUS, INTRAMUSCULAR

Medical Information

N07AA01

neostigmine

Manufacturer Information

DUOPHARMA (SINGAPORE) PTE. LTD.

DUOPHARMA (M) SDN BHD

Active Ingredients

NEOSTIGMINE METHYLSULPHATE

2.5 mg/ml

Neostigmine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SETISIN INJECTION 2.5 mg/ml - HSA Approval | MedPath